KIN expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.129170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.278980E-01
Normal-vs-Stage2
1.292610E-01
Normal-vs-Stage3
8.281800E-02
Normal-vs-Stage4
8.769000E-01
Stage1-vs-Stage2
9.457800E-01
Stage1-vs-Stage3
3.533200E-01
Stage1-vs-Stage4
1.950050E-01
Stage2-vs-Stage3
3.273000E-01
Stage2-vs-Stage4
1.246630E-01
Stage3-vs-Stage4
1.077390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.238560E-01
Normal-vs-AfricanAmerican
1.063240E-01
Normal-vs-Asian
5.992400E-02
Caucasian-vs-AfricanAmerican
9.604200E-01
Caucasian-vs-Asian
8.152300E-02
AfricanAmerican-vs-Asian
3.221600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.218780E-01
Normal-vs-Female
1.133600E-01
Male-vs-Female
7.402600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.256600E-01
Normal-vs-Age(41-60Yrs)
2.153200E-01
Normal-vs-Age(61-80Yrs)
8.879800E-02
Normal-vs-Age(81-100Yrs)
3.417600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.140600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.747200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.183000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.747700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.915600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.272600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.432960E-01
Normal-vs-Daily Drinker
5.509600E-02
Normal-vs-Weekly Drinker
2.895000E-01
Normal-vs-Occasional Drinker
1.849560E-02
Normal-vs-Social Drinker
9.742500E-02
Non Drinker-vs-Daily Drinker
7.057200E-01
Non Drinker-vs-Weekly Drinker
5.139600E-01
Non Drinker-vs-Occasional Drinker
9.116400E-01
Non Drinker-vs-Social Drinker
9.672400E-01
Daily Drinker-vs-Weekly Drinker
3.122200E-01
Daily Drinker-vs-Occasional Drinker
5.819400E-01
Daily Drinker-vs-Social Drinker
7.553800E-01
Weekly Drinker-vs-Occasional Drinker
5.335000E-01
Weekly Drinker-vs-Social Drinker
5.152400E-01
Occasional Drinker-vs-Social Drinker
8.776200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.623900E-02
Normal-vs-Grade 2
1.422170E-02
Normal-vs-Grade 3
2.980400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.773190E-01
Grade 1-vs-Grade 3
3.251400E-01
Grade 1-vs-Grade 4
8.623900E-02
Grade 2-vs-Grade 3
8.247400E-01
Grade 2-vs-Grade 4
1.422170E-02
Grade 3-vs-Grade 4
2.980400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.778100E-02
Normal-vs-NonDiabetic
7.456200E-02
Diabetic-vs-NonDiabetic
9.218200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.537160E-01
Normal-vs-NoPancreatitis
7.616300E-02
Pancreatitis-vs-NoPancreatitis
9.144000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.171500E-02
Normal-vs-N1
1.366390E-01
N0-vs-N1
8.414800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.177600E-01
Normal-vs-TP53-NonMutant
1.499030E-01
TP53-Mutant-vs-TP53-NonMutant
2.098000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
